Select Medical Holdings Corp
NYSE:SEM

Watchlist Manager
Select Medical Holdings Corp Logo
Select Medical Holdings Corp
NYSE:SEM
Watchlist
Price: 15.64 USD 1.43% Market Closed
Market Cap: 1.9B USD

Select Medical Holdings Corp
Investor Relations

Select Medical Holdings Corp. operates in a nuanced and complex healthcare environment, transforming the landscape of rehabilitation and critical illness recovery. Founded in 1996, the company embarked on its journey with a vision to bridge gaps in post-acute care, establishing a network that today includes long-term acute care hospitals, inpatient rehabilitation facilities, and outpatient clinics. This vast network caters to individuals requiring extended medical care, rehabilitation, or therapy following serious illnesses or injuries. The company's operational model revolves around specialized healthcare services, offering a continuum of care that supports patient recovery from severe health conditions to regaining independence.

At the heart of Select Medical's business strategy is its ability to monetize diversified segments within healthcare. The company generates revenue through its hospital and outpatient divisions. Long-term acute care hospitals serve patients with critical, acute, and chronic illnesses over extended periods, while inpatient rehabilitation facilities provide intensive therapy and rehabilitation programs. Furthermore, their outpatient rehabilitation clinics offer physical, occupational, and speech therapy to a broader demographic. This multi-faceted approach not only addresses various healthcare needs but also stabilizes revenue streams by reducing dependency on any single segment. By creating a synergy between its service lines, Select Medical positions itself as a comprehensive service provider, maximizing its capability to benefit from the intricate dynamics of the healthcare sector.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2025
Call Date
Oct 31, 2025
AI Summary
Q3 2025

Revenue Growth: Consolidated revenue grew over 7% to $1.36 billion, reflecting strong performance, especially in the inpatient rehab and critical illness segments.

EPS Guidance Raised: Full-year EPS guidance was increased to $1.14–$1.24, while revenue and adjusted EBITDA guidance were reaffirmed.

Regulatory Tailwind: The delay of the CMS 20% transmittal rule resulted in a one-time $12–$15 million EBITDA benefit this quarter and is expected to have a much smaller impact next year.

Outpatient Pressure: The outpatient rehab segment faced margin compression due to Medicare rate cuts and unfavorable payer mix, with EBITDA margin declining to 7.4%.

Active Development: The company continues significant expansion in inpatient rehab, planning to add nearly 400 beds through 2027 and investing in multiple new joint ventures.

Stable Labor Environment: Labor costs are now stable, with agency rates back to pre-COVID levels and overall wage inflation under 3%.

Capital Allocation: The board approved a dividend of $0.0625 per share, and leverage at 3.4x is viewed as comfortable; capital allocation remains opportunistic.

Key Financials
Revenue
$1.36 billion
Adjusted EBITDA
$111.7 million
Earnings per Common Share
$0.23
Critical Illness Recovery Hospital Revenue
$609.9 million
Critical Illness Recovery Hospital Adjusted EBITDA
$56.1 million
Critical Illness Recovery Hospital Adjusted EBITDA Margin
9.2%
Critical Illness Recovery Hospital Occupancy
65%
Inpatient Rehab Hospital Revenue
$328.6 million
Inpatient Rehab Hospital Adjusted EBITDA
$68 million
Inpatient Rehab Hospital Adjusted EBITDA Margin
20.7%
Inpatient Rehab Hospital Occupancy
83%
Inpatient Rehab Hospital Same-Store Occupancy
86%
Outpatient Rehab Revenue
$325.4 million
Outpatient Rehab Adjusted EBITDA
$24.2 million
Outpatient Rehab Adjusted EBITDA Margin
7.4%
Outpatient Rehab Net Revenue per Visit
$100
Cash Flow from Operating Activities
$175.3 million
Debt Outstanding
$1.8 billion
Net Leverage
3.4x
Days Sales Outstanding
56 days
Dividend per Share
$0.0625
Earnings Call Recording
Other Earnings Calls

Management

Mr. Robert A. Ortenzio
Co-Founder & Executive Chairman
No Bio Available
Mr. David S. Chernow
Chief Executive Officer
No Bio Available
Mr. Michael F. Malatesta
Executive VP & CFO
No Bio Available
Mr. Michael E. Tarvin
Senior Executive VP, General Counsel & Secretary
No Bio Available
Mr. Martin F. Jackson
Senior Executive Vice President of Strategic Finance & Operations
No Bio Available
Mr. Thomas P. Mullin
Co-President
No Bio Available
Mr. Christopher S. Weigl
Senior VP, Controller & Chief Accounting Officer
No Bio Available
Mr. Brian R. Rusignuolo
Executive VP & Chief Information Officer
No Bio Available
Mr. Robert G. Breighner Jr.
Senior Vice President of Compliance & Audit
No Bio Available

Contacts

Address
PENNSYLVANIA
Mechanicsburg
4714 Gettysburg Rd
Contacts